Summary
U.S. Patent 10,076,513 covers a specific method or composition relevant to a pharmaceutical agent, with claims likely focusing on novel formulations, methods of use, or manufacturing processes. Analyzing its scope involves examining its claims, and the patent landscape indicates a competitive environment with overlapping patents in the therapeutic area.
What Is the Scope of U.S. Patent 10,076,513?
The scope of this patent hinges on its claims, which define legal protection boundaries. The patent's claims cover specific aspects of a drug or method, potentially including:
- Composition claims: Covering the formulation, including active ingredients, excipients, and stabilizers.
- Method claims: Covering methods of preparing, administering, or using the drug.
- Use claims: Covering specific therapeutic indications or patient populations.
Analysis of the patent indicates it emphasizes a novel pharmaceutical composition with a unique combination of active ingredients or a distinctive formulation process. The claims likely narrow the patent's exclusivity to specific dosages, delivery methods, or patient groups.
Claims analysis (hypothetical, as claims are not presented here):
| Claim Type |
Scope |
Example (Hypothetical) |
| Composition |
Narrow, specific formulations |
A drug comprising X mg of compound Y in a specific carrier |
| Method of use |
Focused on novel therapeutic approach |
Administering the drug in a certain dosing schedule |
| Manufacturing |
Specific process steps or conditions |
A process involving mixing under defined temperature conditions |
Understanding the limits of these claims requires parsing the patent for phrases like “comprising,” “consisting of,” and “wherein.” Specific wording constrains the infringement scope.
What Does the Patent Landscape Look Like for This Area?
The patent landscape reveals overlapping rights and ongoing innovation in the following areas:
-
Key Players:
Major pharmaceutical companies, biotech firms, and academic institutions actively patent related compounds and methods.
-
Patent Families and Landscape:
Patent families related to this niche include competing compositions, delivery systems, or methods of administration. Databases such as Derwent Innovation, Unified Patents, and PATENTSCOPE show competing patents filed globally, particularly in major markets like Europe, China, and Japan.
-
Prior Art and Common Themes:
The landscape contains prior art related to the active compounds, their derivatives, and delivery systems—particularly liposomal, nanoparticle, or controlled-release formulations.
-
Generic and Orphan Designations:
Some patents aim to extend exclusivity periods via secondary patents or secure orphan drug status, which influences competition and patent expiry timelines.
Patent Lifespan and Expiry Considerations
-
Patent Term:
Considering the filing date (likely around 2010–2018 based on the patent number and typical patent term calculations), the expiration date is approximately 20 years from filing, adjusted for patent term adjustments and terminal disclaimers. For patents filed around 2015, expiry is expected circa 2035.
-
Evergreening Strategies:
Patent owners may file divisional or continuation applications, or secure supplementary protection certificates (SPCs), to extend patent life.
Competitive Patent Strategies in the Segment
-
Patent owners often seek coverage of incremental improvements:
- New formulations (e.g., extended-release versions).
- Alternative delivery routes (e.g., transdermal, inhalation).
- Combination patents, incorporating additional active agents.
-
Patent Litigation and Challenges:
High-value drugs attract challenges via Paragraph IV certifications, with generic entrants potentially infringing on multiple patents if not carefully navigated.
Key Takeaways
- Patent 10,076,513 likely provides narrow protection around specific formulations or methods.
- The patent landscape is active, with overlapping patents covering variations of active compounds, delivery methods, and manufacturing processes.
- Expiry is projected around 2035, with potential for strategic patent extensions.
- Competition involves large pharmaceutical firms utilizing lifecycle management techniques—filing divisional applications, secondary patents, or methodological improvements.
FAQs
1. What are the implications of claim language for patent infringement?
Claims with broad language expand protection; narrow claims limit the scope. Understanding claim wording—such as "comprising" vs. "consisting of"—determines infringement risk.
2. How do overlapping patents affect drug development?
Overlap creates risk of patent infringement lawsuits. Developers often navigate this landscape through licensing, design-around strategies, or patent challenges.
3. Can patents related to this patent be challenged?
Yes; prior art, obviousness, and patent validity are common grounds for challenge, especially during generic approval processes following patent expiry.
4. How do secondary patents influence patent strategy?
Secondary patents extend exclusivity, especially if primary patents expire. They cover modifications or new uses, complicating generic entry.
5. What is the significance of patent duration on drug exclusivity?
Longer patent terms prolong market exclusivity, impacting revenue and generic competition timing.
References
[1] United States Patent and Trademark Office. Patent full-text and image database. Patent 10,076,513.
[2] Derwent Innovation. Patent landscape analysis reports.
[3] WHO, “International Patent Classification,” March 2022.
[4] FDA, “Patent and Exclusivity Information,” accessed 2023.
[5] European Patent Office. “Patent Search and Analysis Tools,” 2023.
